JD Health International, Inc. (HK:6618) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
JD Health International, Inc. reported a significant rise in revenue and profits for the third quarter of 2024, with revenue increasing by 14.8% and profit surging by 212.2% compared to the same period in 2023. The company expanded its pharmaceutical offerings and online medical services, enhancing its service model by integrating online consultations and at-home testing services in major cities like Beijing and Shanghai. JD Health also introduced online payment services through medical insurance accounts, further solidifying its position in the healthcare market.
For further insights into HK:6618 stock, check out TipRanks’ Stock Analysis page.